CorVel (NASDAQ:CRVL) Sets New 1-Year Low – Should You Sell?

CorVel Corp. (NASDAQ:CRVL)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as $65.95 and last traded at $65.9250, with a volume of 11636 shares changing hands. The stock had previously closed at $67.67.

Wall Street Analysts Forecast Growth

CRVL has been the subject of several research analyst reports. Wall Street Zen lowered shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a research report on Tuesday, October 14th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the company has a consensus rating of “Hold”.

CorVel Trading Down 2.4%

The firm has a market capitalization of $3.39 billion, a price-to-earnings ratio of 32.43 and a beta of 1.07. The company’s 50 day moving average is $71.96 and its 200-day moving average is $82.48.

CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Tuesday, November 4th. The business services provider reported $0.54 earnings per share (EPS) for the quarter. CorVel had a return on equity of 31.72% and a net margin of 11.28%.The firm had revenue of $239.64 million for the quarter.

Insider Activity

In related news, Director R Judd Jessup sold 7,076 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $76.94, for a total value of $544,427.44. Following the transaction, the director owned 115,045 shares in the company, valued at approximately $8,851,562.30. This represents a 5.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Mark E. Bertels sold 1,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $72.35, for a total transaction of $86,820.00. Following the sale, the executive vice president owned 2,594 shares of the company’s stock, valued at $187,675.90. This trade represents a 31.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 11,733 shares of company stock valued at $894,686 in the last ninety days. 44.56% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in CorVel by 0.7% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock worth $1,640,000 after acquiring an additional 115 shares during the period. The Manufacturers Life Insurance Company grew its stake in CorVel by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock worth $1,636,000 after buying an additional 139 shares in the last quarter. Arizona State Retirement System increased its holdings in CorVel by 1.7% in the 3rd quarter. Arizona State Retirement System now owns 9,113 shares of the business services provider’s stock valued at $706,000 after buying an additional 155 shares during the period. Atria Investments Inc increased its holdings in CorVel by 1.3% in the 2nd quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock valued at $1,505,000 after buying an additional 186 shares during the period. Finally, ProShare Advisors LLC raised its position in shares of CorVel by 3.0% in the 2nd quarter. ProShare Advisors LLC now owns 6,466 shares of the business services provider’s stock valued at $665,000 after buying an additional 189 shares in the last quarter. 51.36% of the stock is owned by institutional investors.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).